Loading clinical trials...
Loading clinical trials...
Effectiveness of an Image Analysing Algorithm to Diagnose Melanoma Compared to Gold Standard Histological Determination
Prospective, single-arm, cross-sectional, study to establish the effectiveness of MIAA to detect melanoma in pigmented lesions, compared to gold standard histological determination.
Skin Analytics Limited have developed an algorithm (MIAA) which reviews photographs of pigmented lesions to determine whether melanoma is likely to be present. This study aims to establish how well MIAA determines the presence or absence of melanoma, compared to a biopsy. Pigmented lesions that a dermatologist has decided to biopsy, and are suitable for photographing, will be photographed up to five times in a single visit. Three different camera will be used, and two different dermoscopic lens attachments will be used on smartphone cameras. Images will be analysed by MIAA and the results compared to the biopsy result. Clinicians, patients and the statistical analysis team will be blinded to the result of MIAA. At least 65 pigmented lesions positive for melanoma (as determined by biopsy) are required, which is predicted to mean 1250 patients will be recruited.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Royal Devon and Exeter
Exeter, Devon, United Kingdom
Whipps Corss Hospital
Leytonstone, London, United Kingdom
Royal Stoke University Hospital
Stoke, Staffordshire, United Kingdom
Russells Hall Hospital
Dudley, West Midlands, United Kingdom
Bristol Royal Infirmary
Bristol, United Kingdom
Royal Free London NHS Foundation Trust
London, United Kingdom
Churchill Hospital
Oxford, United Kingdom
Start Date
January 11, 2017
Primary Completion Date
July 11, 2018
Completion Date
July 11, 2018
Last Updated
January 25, 2019
514
ACTUAL participants
Melanoma Image Analysis Algorithm (MIAA)
DEVICE
Lead Sponsor
Skin Analytics Limited
NCT07371663
NCT01898039
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06209580